Endometrial adenocarcinoma: An apostasy from early views [1]

Gynecologic Oncology

Volumn 95, Issue 3, 2004, Pages 772-773

  Sivridis, E ^a   Giatromanolaki, A ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

CANCER STAGING; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HISTOLOGY; HORMONAL REGULATION; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS;

EID: 9944223355     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.08.017     Document Type: Letter

References (16)

1. T.S. Cullen Cancer of the uterus. Its Pathology, Symptomatology, Diagnosis, and Treatment 1900 Henry Kimpton London
2. J.V. Bokhman Two pathogenetic types of endometial carcinoma Gynecol. Oncol. 15 1983 10 17
3. M.E. Beckner, I. Mori, and S.G. Silverberg Endometrial carcinoma: nontumor factors in prognosis Int. J. Gynecol. Pathol. 4 1985 131 145
4. L. Deligdisch, and C.J. Cohen Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia Cancer 56 1985 1452 1455
5. S.B. Gusberg The changing nature of endometrial cancer N. Engl. J. Med. 302 1980 709 732
6. E. Sivridis, and A. Giatromanolaki Endometrial adenocarcinoma: beliefs and skepticism Int. J. Surg. Pathol. 12 2004 95 105
7. E. Sivridis, and A. Giatromanolaki Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma J. Clin. Pathol. 57 2004 840 844
8. E. Sivridis, H. Fox, and C.H. Buckley Endometrial carcinoma: two or three entities? Int. J. Gynecol. Cancer 8 1998 183 188
9. E. Sivridis, and A. Giatromanolaki Prognostic aspects on endometrial hyperplasia and neoplasia Virchows Arch. 439 2001 118 126
10. C.H. Buckley, and H. Fox Biopsy pathology of the endometrium 2nd ed. 2002 Arnold London
11. K.M. Alektiar, A. McKee, O. Lin, E. Venkatraman, M.J. Zelefsky, and B. McKee Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO 3 cancer? Int. J. Radiat. Oncol., Biol., Phys. 54 2002 79 85
12. M.R. Hendrickson, J.C. Ross, P.J. Eifel, R. Martinez, and R.L. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am. J. Surg. Pathol. 6 1982 93 108
13. V.M. Abeler, I.B. Vergote, K.E. Kjorstad, and C.G. Trope Clear cell carcinoma of the endometrium: prognosis and metastatic pattern Cancer 78 1996 1740 1747
14. P.K. Siiteri, and P.C. Macdonald Role of extraglandular estrogen in human endocrinology R.O. Greep E.B. Astwood Handbook of Physiology; Section 7 Endocrinology vol. II, part 1 1973 American Physiological Society Washington, DC 615 629
15. Announcements FIGO stages-1988 revision Gynecol. Oncol. 35 1989 125 127
16. R. Zaino, R.J. Kurman, K. Diana, and C. Morrow The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system Cancer 75 1995 81 86